Assessing major complications in patients with thoracic aortic aneurysm
Official title: Predicting Moderate Thoracic Aortic Aneurysm Evolution: a Longitudinal Study of Systemic Factors in Patients Free of Connective Tissue Disease. .
Run by University Hospital, Lille · NCT05395598 · Data updated 2026-11-12
This study is trying to see how often serious problems happen in people with small to moderate thoracic aortic aneurysms over five years and what factors might affect their condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years to 80 Years |
| Sex | All |
| Enrollment | 320 (estimated) |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 1 site (Lille, Please Choose...) |
| Status | Recruiting |
| Started | April 18, 2024 |
| Main results expected | April 18, 2031 |
| Study ends | October 2031 |
| Registry record updated | May 15, 2026 |
| Trial ID | NCT05395598 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals with a documented thoracic aortic aneurysm greater than 40 mm who can commit to a five-year follow-up.
✕Probably not a fit
Patients with significant comorbidities, advanced aneurysm progression, or a history of aortic surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the incidence of major complications in patients diagnosed with small to moderate thoracic aortic aneurysms over a five-year follow-up period. It will investigate various systemic factors, such as high blood pressure and sleep disorders, that may influence the progression of the aneurysm. Participants will undergo regular imaging and clinical assessments to monitor their condition and identify any complications that arise. The study seeks to fill the gap in existing data regarding the risks associated with thoracic aortic aneurysms.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the management and monitoring of patients with thoracic aortic aneurysms, potentially improving patient outcomes.
How similar studies have gone: While there is limited data on the specific incidence of complications in small to moderate thoracic aortic aneurysms, similar observational studies have provided valuable insights into aneurysm management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Documentation of an aortic root aneurysm \> 40 mm * Agreement to participate to a longitudinal study and available for a 5 years follow-up Exclusion Criteria: * Presence of comorbidities or pathology with a prognosis of less than 1 year * Personal or family history of genetically documented elastic tissue disease or patient meeting the GAND clinical criteria suggestive of Marfan disease * High-grade mitra-aortic valve disease, even if asymptomatic * Unbalanced hypertension ≥ 180/110 mmHg * Aneurysm (regardless of thoracic or abdominal location) ≥ 50 mm * Aneurysm (regardless of thoracic or abdominal location) with documented progression of more than 5 mm over one year * History of aortic surgery or endovascular intervention and history of type B aortic dissection of medical treatment * Renal insufficiency on dialysis, or GFR\< 30 ml/mn (CKD-EPI)
Where it's running
-
CHU Lille
Lille, Please Choose..., France Recruiting
Study contacts
- Principal investigator: Pascal DELSART, MD — University Hospital, Lille
- Study coordinator: Pascal DELSART, MD
- Email: pascal.DELSART@chru-Lille.fr
- Phone: 0320445962
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
GORE MBA Arch Endoprosthesis Early Feasibility Study
This study tests the safety of the MBA device in people with arch-related thoracic aortic diseases to see if it can be used safely in real-world settings.
-
See if spironolactone can reduce aortic stiffness in adults with thoracic aortic aneurysm
This study tests whether spironolactone reduces aortic stiffness compared with placebo in adults with degenerative thoracic aortic aneurysms.
-
Evaluating outcomes of thoracic aortic repair in patients with compromised landing zones
This study is testing different stent-graft options for patients with aortic aneurysms who have tricky anatomy to see if they can prevent complications after surgery.
-
Advancing genomic medicine using electronic health records
This study is trying to see if using electronic health records and helpful reminders can get more patients tested for genetic conditions in a way that doctors can easily use.
-
Exploring genetic factors in acute aortic conditions
This study is testing whether looking at the genes of people with aortic dissection or aneurysm can help doctors better predict who is at risk and improve their chances of getting timely treatment.
-
Using presepsin levels to guide antibiotic treatment in thoracic aorta surgery patients
This study is testing if measuring a specific marker in the blood can help doctors give the right antibiotics to patients after thoracic aorta surgery to prevent infections and improve recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.